p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.

A M Redman; J S Johnson; R Dally; S Swartz; H Wild; H Paulsen; Y Caringal; D Gunn; J Renick; M Osterhout

doi:10.1016/s0960-894x(00)00574-6

p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.

Identifier:nobleid.org/w1/20260515/B7427AF2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B7427AF2.svg?ark=w1%2F20260515%2FB7427AF2)](https://nobleid.org/work/w1/20260515/B7427AF2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.

Identifier:nobleid.org/w1/20260515/B7427AF2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B7427AF2.svg?ark=w1%2F20260515%2FB7427AF2)](https://nobleid.org/work/w1/20260515/B7427AF2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work